SCHEMBL7681152

SCHEMBL7681152

c1cc(CNCCN2CCOCC2)cc(N2CCOCC2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.55
CYP3A4 P08684 4/20 0.55
CYP2C19 P33261 2/20 0.55
POLB P06746 1/20 0.47
ALDH1A1 P00352 1/20 0.46
TNKS2 Q9H2K2 1/20 0.46
MAP4K4 O95819 1/20 0.45
PIK3CA P42336 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 1/20 0.44
PDGFRB P09619 1/20 0.43
KDR P35968 1/20 0.43
HTT P42858 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7677919 0.93 CYP2C19 (0.67) CYP2D6CYP3A4CYP2C19POLBALDH1A1
SCHEMBL7679598 0.92 CYP3A4 (0.58) CYP2D6CYP3A4CYP2C19POLBALDH1A1
SCHEMBL7682114 0.88 CYP2C19 (0.60) CYP2D6CYP3A4CYP2C19ALDH1A1PIK3CA
SCHEMBL7679073 0.81 CYP3A4 (0.45) CYP2D6CYP3A4CYP2C19PIK3CAKDM4E
SCHEMBL10210050 0.80 PIK3CA (0.50) PIK3CAKDM4EMAPTHTT
SCHEMBL10154083 0.80 PIK3CA (0.50) CYP3A4CYP2C19ALDH1A1PIK3CAKDM4E
SCHEMBL3166127 0.77 CYP2D6 (0.65) CYP2D6CYP3A4CYP2C19POLBALDH1A1
SCHEMBL24455071 0.77 RAB9A (0.53) CYP2C19ALDH1A1PIK3CAKDM4ELMNA
SCHEMBL29561895 0.77 RAB9A (0.53) CYP2C19ALDH1A1PIK3CAKDM4ELMNA
SCHEMBL8197483 0.75 PIK3CA (0.59) CYP2C19PIK3CAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 US disclosed